Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements

Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-10-28. On CanQuery you can follow the original downloads. Files are available in English and French.

This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-10-28

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data